NXTRA

Serial Number 85620881
606

Registration Progress

Application Filed
May 9, 2012
Under Examination
Dec 4, 2012
Approved for Publication
Oct 9, 2012
Published for Opposition
Oct 9, 2012
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: NXTRA
Previous Owner: Antares Pharma, Inc.
Classes: 005

Trademark Image

NXTRA

Basic Information

Serial Number
85620881
Filing Date
May 9, 2012
Published for Opposition
October 9, 2012
Abandonment Date
July 8, 2013
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 8, 2013
Classes
005

Rights Holder

Antares Pharma, Inc.

03
Address
100 Princeton South Corp. Ctr Suite 300
Ewing, NJ 08628

Ownership History

Antares Pharma, Inc.

Original Applicant
03
Ewing, NJ

Antares Pharma, Inc.

Owner at Publication
03
Ewing, NJ

Legal Representation

Attorney
Ahmed M.T. Riaz

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

10 events
Date Code Type Description Documents
Jul 8, 2013 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jul 8, 2013 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 4, 2012 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 9, 2012 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 9, 2012 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 19, 2012 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 4, 2012 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 29, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
May 16, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 12, 2012 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of rheumatoid arthritis
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005